APAC Dyspepsia Drug Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	393 Pages	Data Bridge Market Research	May, 2023	DAABD18011501

Best Price Guarantee
Price	from $3,500
Length	393 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2023
SKU	DAABD18011501

APAC Dyspepsia Drug Market - Industry Trends and Forecast to 2030

Asia-Pacific dyspepsia drug market is expected to reach USD 183,671.18 thousand by 2030 from USD 114,763.07 thousand in 2022, growing at a CAGR of 6.1% during the forecast period of 2023 to 2030.
Market Segmentation:
Asia-Pacific Dyspepsia Drug Market, By Type (Organic Dyspepsia, Non-Ulcer Dyspepsia, Drug Induced Dyspepsia, and Others), Treatment Type (Medication and Surgery), Drug Type (Branded and Generic), Prescription (Without Prescription Drugs and Prescription Drugs), Route of Administration (Oral and Injectable), Gender (Male and Female), End-User (Hospitals, Clinics, Homecare settings, Specialty Clinics, Ambulatory Surgical Centers, Academic and Government Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, New Zealand, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia-Pacific Dyspepsia Drug Market Dynamics:

Driver
• Increasing prevalence of dyspepsia

Restrain

• Possible side effects of the drugs used for dyspepsia

Opportunity

• Growing aging population

Market Players:

Some of the key market players operating in the Asia-Pacific dyspepsia drug market are listed below:

• Abbott
• Bayer AG
• Cadila Pharmaceuticals
• Sanofi
• Lupin
• Perrigo Company plc
• Reckitt Benckiser
• AstraZeneca
• Procter & Gamble
• Otsuka Pharmaceutical Co., Ltd.
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction 85: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia-pacific Dyspepsia Drug Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation 91: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market End-user Coverage Grid; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary 104
4 Premium Insight 107: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces
5 Epidemiology 110
6 Problems In The Management Of Dyspepsia 111
7 Industry Insights: 112
8 Asia-pacific Dyspepsia Drug Market, Regulation 113
9 Market Overview 116: 9.1 Drivers; 9.1.1 Increasing Prevalence Of Dyspepsia; 9.1.2 Rise In The Adoption Of Unhealthy Lifestyle; 9.1.3 Increase In The Prevalence Of Metabolic Disorders; 9.2 Restraints; 9.2.1 Possible Side Effects Of The Drugs Used For Dyspepsia; 9.2.2 Increasing Preference For Natural And Herbal Remedies; 9.3 Opportunities; 9.3.1 Growing Aging Population; 9.3.2 Rise In The Drug Approval; 9.4 Challenges; 9.4.1 Lack Of Awareness About Dyspepsia Among The Population; 9.4.2 Stringent Regulations
10 Asia-pacific Dyspepsia Drug Market, By Type 124: 10.1 Overview; 10.2 Non-ulcer Dyspepsia; 10.3 Organic Dyspepsia; 10.4 Drug Induced Dyspepsia; 10.5 Others
11 Asia-pacific Dyspepsia Drug Market, By Treatment Type 131: 11.1 Overview; 11.2 Medication; 11.2.1 Drugs; 11.2.1.1 Antacids; 11.2.1.1.1 Proton Pump Inhibitors (Ppi’s); 11.2.1.1.1.1 Omeprazole; 11.2.1.1.1.2 Lansoprazole; 11.2.1.1.1.3 Esomeprazole; 11.2.1.1.1.4 Others; 11.2.1.1.2 H2 Blockers; 11.2.1.1.2.1 Cimetidine; 11.2.1.1.2.2 Famotidine; 11.2.1.1.2.3 Nizatidine; 11.2.1.1.2.4 Ranitidine; 11.2.1.1.2.5 Others; 11.2.1.2 Gastric Prokinetic Gendernts; 11.2.1.2.1 Mosapride Citrate; 11.2.1.2.2 Metoclopramide; 11.2.1.2.3 Cisapride; 11.2.1.2.4 Itopride Hydrochloride; 11.2.1.2.5 Domperidone; 11.2.1.2.6 Others; 11.2.1.3 Antibiotics; 11.2.1.3.1 Refaximin; 11.2.1.3.2 Amoxicillin; 11.2.1.3.3 Clarithromycin; 11.2.1.3.4 Metronidazole; 11.2.1.3.5 Levofloxacin; 11.2.1.3.6 Tetracycline; 11.2.1.3.7 Others; 11.2.1.4 Others; 11.2.2 Non- Drugs; 11.2.2.1 Probiotics; 11.2.2.1.1 Lactobacillus; 11.2.2.1.2 Bifidobacterium; 11.2.2.1.3 Bacillus; 11.2.2.1.4 Streptococcus; 11.2.2.1.5 Others; 11.2.2.2 Prebiotics; 11.3 Surgery
12 Asia-pacific Dyspepsia Drug Market, By Drug Type 144: 12.1 Overview; 12.2 Generic; 12.3 Branded
13 Asia-pacific Dyspepsia Drug Market, By Prescription 150: 13.1 Overview; 13.2 Without Prescription Drugs; 13.3 Prescription Drugs
14 Asia-pacific Dyspepsia Drug Market, By Route Of Administration 156: 14.1 Overview; 14.2 Oral; 14.2.1 Tablets; 14.2.2 Capsules; 14.3 Injectable
15 Asia-pacific Dyspepsia Drug Market, By Gender 162: 15.1 Overview; 15.2 Female; 15.2.1 30-50 Years; 15.2.2 More Than 50 Years; 15.2.3 Age Less Than 30; 15.3 Male; 15.3.1 30-50 Years; 15.3.2 More Than 50 Years; 15.3.3 Age Less Than 30
16 Asia-pacific Dyspepsia Drug Market, By End User 169: 16.1 Overview; 16.2 Hospitals; 16.2.1 Type; 16.2.1.1 Public; 16.2.1.2 Private; 16.2.2 Tier; 16.2.2.1 Tier 3; 16.2.2.2 Tier 2; 16.2.2.3 Teir 1; 16.3 Clinics; 16.4 Homecare Settings; 16.5 Specialty Clinics; 16.6 Ambulatory Centers; 16.7 Academic And Government Research Institutes; 16.8 Others
17 Asia-pacific Dyspepsia Drug Market, By Distribution Channel 179: 17.1 Overview; 17.2 Retail Sales; 17.2.1 Reatil Pharmacy; 17.2.2 Hospital Pharmacy; 17.2.3 Online Pharmacy; 17.3 Direct Tender
18 Asia-pacific Dyspepsia Drug Market, By Region 185: 18.1 Asia-pacific; 18.1.1 Japan; 18.1.2 China; 18.1.3 South Korea; 18.1.4 India; 18.1.5 Australia; 18.1.6 New Zealand; 18.1.7 Singapore; 18.1.8 Thailand; 18.1.9 Indonesia; 18.1.10 Malaysia; 18.1.11 Philippines; 18.1.12 Vietnam; 18.1.13 Taiwan; 18.1.14 Rest Of Asia-pacific
19 Asia-pacific Dyspepsia Drug Market, Company Landscape 345: 19.1 Company Share Analysis: Asia-pacific
20 Swot Analysis 346
21 Asia-pacific Dyspepsia Drug Market, Company Profilings 347: 21.1 Sanofi; 21.1.1 Company Snapshot; 21.1.2 Revenue Analysis; 21.1.3 Company Share Analysis; 21.1.4 Product Portfolio; 21.1.5 Recent Development; 21.2 Lupin; 21.2.1 Company Snapshot; 21.2.2 Revenue Analysis; 21.2.3 Company Share Analysis; 21.2.4 Product Portfolio; 21.2.5 Recent Developments; 21.3 Mankind Pharma; 21.3.1 Company Snapshot; 21.3.2 Revenue Analysis; 21.3.3 Company Share Analysis; 21.3.4 Product Portfolio; 21.3.5 Recent Development; 21.4 Astrazeneca; 21.4.1 Company Snapshot; 21.4.2 Revenue Analysis; 21.4.3 Company Share Analysis; 21.4.4 Product Portfolio; 21.4.5 Recent Development; 21.5 Bayer Ag; 21.5.1 Company Snapshot; 21.5.2 Revenue Analysis; 21.5.3 Company Share Analysis; 21.5.4 Product Portfolio; 21.5.5 Recent Development; 21.6 Abbott; 21.6.1 Company Snapshot; 21.6.2 Revenue Analysis; 21.6.3 Product Portfolio; 21.6.4 Recent Development; 21.7 Ani Pharmaceuticals, Inc.; 21.7.1 Company Snapshot; 21.7.2 Revenue Analysis; 21.7.3 Product Portfolio; 21.7.4 Recent Development; 21.8 Aosaikang Pharmaceutical Co., Ltd.; 21.8.1 Company Snapshot; 21.8.2 Revenue Analysis; 21.8.3 Product Portfolio; 21.8.4 Recent Development; 21.9 Asterisk Laboratories (I) Pvt. Ltd; 21.9.1 Company Snapshot; 21.9.2 Product Portfolio; 21.9.3 Recent Development; 21.10 Cadila Pharmaceuticals; 21.10.1 Company Snapshot; 21.10.2 Revenue Analysis; 21.10.3 Company Share Analysis; 21.10.4 Product Portfolio; 21.10.5 Recent Development; 21.11 Hanmi Pharm. Co., Ltd.; 21.11.1 Company Snapshot; 21.11.2 Revenue Analysis; 21.11.3 Product Portfolio; 21.11.4 Recent Development; 21.12 Mcneil Consumer Pharmaceuticals Co. (A Subsidiary Of Johnson & Johnson Services, Inc.); 21.12.1 Company Snapshot; 21.12.2 Revenue Analysis; 21.12.3 Product Portfolio; 21.12.4 Recent Development; 21.13 Otsuka Pharmaceutical Co., Ltd.; 21.13.1 Company Snapshot; 21.13.2 Revenue Analysis; 21.13.3 Product Portfolio; 21.13.4 Recent Development; 21.14 Perrigo Company Plc; 21.14.1 Company Snapshot; 21.14.2 Revenue Analysis; 21.14.3 Product Portfolio; 21.14.4 Recent Development; 21.15 Prestige Consumer Healthcare, Inc.; 21.15.1 Company Snapshot; 21.15.2 Revenue Analysis; 21.15.3 Product Portfolio; 21.15.4 Recent Development
List Of Tables: Table 1 Asia-pacific Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 2 Asia-pacific Non-ulcer Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 3 Asia-pacific Organic Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 4 Asia-pacific Drug Induced Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 5 Asia-pacific Others In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 6 Asia-pacific Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 7 Asia-pacific Medication In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 8 Asia-pacific Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 9 Asia-pacific Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 10 Asia-pacific Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 11 Asia-pacific Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 12 Asia-pacific H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 13 Asia-pacific Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 14 Asia-pacific Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 15 Asia-pacific Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 16 Asia-pacific Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 17 Asia-pacific Surgery In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 18 Asia-pacific Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand); Table 19 Asia-pacific Generic In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 20 Asia-pacific Branded In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 21 Asia-pacific Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand); Table 22 Asia-pacific Without Prescription Drugs In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 23 Asia-pacific Prescription Drugs In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 24 Asia-pacific Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 25 Asia-pacific Oral In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 26 Asia-pacific Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 27 Asia-pacific Injectable In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 28 Asia-pacific Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand); Table 29 Asia-pacific Female In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 30 Asia-pacific Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 31 Asia-pacific Male In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 32 Asia-pacific Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 33 Asia-pacific Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand); Table 34 Asia-pacific Hospitals In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 35 Asia-pacific Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 36 Asia-pacific Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand); Table 37 Asia-pacific Clinics In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 38 Asia-pacific Homecare Settings In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 39 Asia-pacific Specialty Clinics In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 40 Asia-pacific Ambulatory Centers In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 41 Asia-pacific Academic And Government Research Institutes In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 42 Asia-pacific Others In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 43 Asia-pacific Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 44 Asia-pacific Retail Sales In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 45 Asia-pacific Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 46 Asia-pacific Direct Tender In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand); Table 47 Asia-pacific Dyspepsia Drug Market, By Country, 2021-2030 (Usd Thousand); Table 48 Asia-pacific Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 49 Asia-pacific Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 50 Asia-pacific Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 51 Asia-pacific Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 52 Asia-pacific Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 53 Asia-pacific Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 54 Asia-pacific Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 55 Asia-pacific H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030, (Usd Thousands ); Table 56 Asia-pacific H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 57 Asia-pacific Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 58 Asia-pacific Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 59 Asia-pacific Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 60 Asia-pacific Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 61 Asia-pacific Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 62 Asia-pacific Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 63 Asia-pacific Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 64 Asia-pacific Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand); Table 65 Asia-pacific Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand); Table 66 Asia-pacific Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 67 Asia-pacific Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 68 Asia-pacific Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand); Table 69 Asia-pacific Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 70 Asia-pacific Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 71 Asia-pacific Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand); Table 72 Asia-pacific Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 73 Asia-pacific Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand); Table 74 Asia-pacific Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 75 Asia-pacific Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 76 Japan Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 77 Japan Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 78 Japan Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 79 Japan Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 80 Japan Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 81 Japan Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 82 Japan Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 83 Japan Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 84 Japan H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 85 Japan H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 86 Japan H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 87 Japan Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 88 Japan Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 89 Japan Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 90 Japan Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 91 Japan Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 92 Japan Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 93 Japan Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 94 Japan Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 95 Japan Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 96 Japan Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 97 Japan Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand); Table 98 Japan Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand); Table 99 Japan Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 100 Japan Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 101 Japan Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand); Table 102 Japan Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 103 Japan Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 104 Japan Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand); Table 105 Japan Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 106 Japan Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand); Table 107 Japan Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 108 Japan Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 109 .China Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 110 China Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 111 China Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 112 China Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 113 China Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 114 China Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 115 China Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 116 China Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 117 China H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 118 China H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 119 China H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 120 China Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 121 China Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 122 China Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 123 China Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 124 China Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 125 China Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 126 China Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 127 China Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 128 China Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 129 China Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp); Table 130 China Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand); Table 131 China Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand); Table 132 China Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 133 China Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 134 China Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand); Table 135 China Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 136 China Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand); Table 137 China Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand); Table 138 China Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 139 China Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand); Table 140 China Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 141 China Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 142 South Korea Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 143 South Korea Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 144 South Korea Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 145 South Korea Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 146 South Korea Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 147 South Korea Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand); Table 148 South Korea Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units); Table 149 South Korea Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
List Of Figures: Figure 1 Asia-pacific Dyspepsia Drug Market: Segmentation; Figure 2 Asia-pacific Dyspepsia Drug Market: Data Triangulation; Figure 3 Asia-pacific Dyspepsia Drug Market: Droc Analysis; Figure 4 Asia-pacific Dyspepsia Drug Market: Asia-pacific Vs. Regional Market Analysis; Figure 5 Asia-pacific Dyspepsia Drug Market: Company Research Analysis; Figure 6 Asia-pacific Dyspepsia Drug Market: Interview Demographics; Figure 7 Asia-pacific Dyspepsia Drug Market: Multivariate Modelling; Figure 8 Asia-pacific Dyspepsia Drug Market: Dbmr Market Position Grid; Figure 9 Asia-pacific Dyspepsia Drug Market: Vendor Share Analysis; Figure 10 Asia-pacific Dyspepsia Drug Market: Market End-user Coverage Grid; Figure 11 Asia-pacific Dyspepsia Drug Market: Segmentation; Figure 12 Increase In The Prevalence Of Metabolic Disorders Is Expected To Drive The Asia-pacific Dyspepsia Drug Market Growth In The Forecast Period From 2023 To 2030; Figure 13 Non-ulcer Dyspepsia Segment Is Expected To Account For The Largest Share Of The Asia-pacific Dyspepsia Drug Market In 2023 & 2030; Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Asia-pacific Dyspepsia Drug Market; Figure 15 Asia-pacific Dyspepsia Drug Market: By Type, 2022; Figure 16 Asia-pacific Dyspepsia Drug Market: By Type, 2023-2030 (Usd Thousand); Figure 17 Asia-pacific Dyspepsia Drug Market: By Type, Cagr (2023-2030); Figure 18 Asia-pacific Dyspepsia Drug Market: By Type, Lifeline Curve; Figure 19 Asia-pacific Dyspepsia Drug Market: By Treatment Type , 2022; Figure 20 Asia-pacific Dyspepsia Drug Market: By Treatment Type, 2023-2030 (Usd Thousand); Figure 21 Asia-pacific Dyspepsia Drug Market: By Treatment Type , Cagr (2023-2030); Figure 22 Asia-pacific Dyspepsia Drug Market: By Treatment Type , Lifeline Curve; Figure 23 Asia-pacific Dyspepsia Drug Market: By Drug Type, 2022; Figure 24 Asia-pacific Dyspepsia Drug Market: By Drug Type, 2023-2030 (Usd Thousand); Figure 25 Asia-pacific Dyspepsia Drug Market: By Drug Type, Cagr (2023-2030); Figure 26 Asia-pacific Dyspepsia Drug Market: By Drug Type, Lifeline Curve; Figure 27 Asia-pacific Dyspepsia Drug Market: By Prescription, 2022; Figure 28 Asia-pacific Dyspepsia Drug Market: By Prescription, 2023-2030 (Usd Thousand); Figure 29 Asia-pacific Dyspepsia Drug Market: By Prescription, Cagr (2023-2030); Figure 30 Asia-pacific Dyspepsia Drug Market: By Prescription, Lifeline Curve; Figure 31 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, 2022; Figure 32 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, 2023-2030 (Usd Thousand); Figure 33 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, Cagr (2023-2030); Figure 34 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, Lifeline Curve; Figure 35 Asia-pacific Dyspepsia Drug Market: By Gender, 2022; Figure 36 Asia-pacific Dyspepsia Drug Market: By Gender, 2023-2030 (Usd Thousand); Figure 37 Asia-pacific Dyspepsia Drug Market: By Gender, Cagr (2023-2030); Figure 38 Asia-pacific Dyspepsia Drug Market: By Gender, Lifeline Curve; Figure 39 Asia-pacific Dyspepsia Drug Market: By End User, 2022; Figure 40 Asia-pacific Dyspepsia Drug Market: By End User, 2023-2030 (Usd Thousand); Figure 41 Asia-pacific Dyspepsia Drug Market: By End User, Cagr (2023-2030); Figure 42 Asia-pacific Dyspepsia Drug Market: By End User, Lifeline Curve; Figure 43 Asia-pacific Dyspepsia Drug Market: By Distribution Channel, 2022; Figure 44 Asia-pacific Dyspepsia Drug Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 45 Asia-pacific Dyspepsia Drug Market: By Distribution Channel, Cagr (2023-2030); Figure 46 Asia-pacific Dyspepsia Drug Market: By Distributi